Riverbridge Partners LLC lessened its position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 26.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 652,715 shares of the business services provider's stock after selling 231,077 shares during the period. Riverbridge Partners LLC owned 1.29% of Exponent worth $58,157,000 at the end of the most recent reporting period.
Other hedge funds have also bought and sold shares of the company. Heritage Family Offices LLP increased its stake in Exponent by 3.8% in the fourth quarter. Heritage Family Offices LLP now owns 3,123 shares of the business services provider's stock valued at $278,000 after purchasing an additional 114 shares in the last quarter. Mitchell & Pahl Private Wealth LLC boosted its holdings in Exponent by 3.7% during the third quarter. Mitchell & Pahl Private Wealth LLC now owns 5,961 shares of the business services provider's stock worth $687,000 after purchasing an additional 214 shares during the last quarter. Westside Investment Management Inc. purchased a new position in Exponent in the third quarter valued at about $26,000. PNC Financial Services Group Inc. boosted its stake in Exponent by 2.2% in the third quarter. PNC Financial Services Group Inc. now owns 11,134 shares of the business services provider's stock valued at $1,284,000 after acquiring an additional 239 shares during the last quarter. Finally, GAMMA Investing LLC boosted its stake in Exponent by 64.6% in the third quarter. GAMMA Investing LLC now owns 624 shares of the business services provider's stock valued at $72,000 after acquiring an additional 245 shares during the last quarter. Institutional investors own 92.37% of the company's stock.
Exponent Trading Down 0.7 %
Shares of NASDAQ EXPO traded down $0.68 during midday trading on Thursday, hitting $92.26. The company's stock had a trading volume of 65,105 shares, compared to its average volume of 196,044. Exponent, Inc. has a one year low of $68.70 and a one year high of $115.75. The firm has a market capitalization of $4.68 billion, a price-to-earnings ratio of 44.57 and a beta of 0.71. The stock has a fifty day moving average price of $93.33 and a 200 day moving average price of $101.46.
Insider Buying and Selling
In other Exponent news, Director Paul R. Johnston sold 1,300 shares of the stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $95.03, for a total transaction of $123,539.00. Following the completion of the sale, the director now owns 59,406 shares of the company's stock, valued at $5,645,352.18. This represents a 2.14 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Carol Lindstrom sold 1,039 shares of the stock in a transaction on Monday, November 4th. The shares were sold at an average price of $96.32, for a total transaction of $100,076.48. Following the sale, the director now directly owns 5,871 shares of the company's stock, valued at $565,494.72. The trade was a 15.04 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 30,339 shares of company stock worth $3,103,065. Corporate insiders own 2.10% of the company's stock.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.